No Data
The Social Security Fund's annual report on Hold Positions has been revealed! A total of 52 new stocks entered the top ten circulating Shareholders list, with China Resources Double-Crane Pharmaceutical receiving the most Shareholding increases.
① With the continuous disclosure of the 2024 annual reports of listed companies, the Social Security Fund has newly entered the top ten circulating shareholders list of 52 individual stocks; ② Among them, China Resources Double-Crane Pharmaceutical has the highest number of new holdings by the Social Security Fund, reaching 3; ③ Attached is the list of A-shares where the number of newly added Institutions held by the Social Security Fund in the fourth quarter of 2024 ranks highest (attached table).
CR Double-Crane Pharmaceutical Obtains Drug Registration for Contrast Agent
China Resources Double-Crane Pharmaceutical (600062.SH): Gadobutrol injection has obtained the Pharmaceutical registration certificate.
On March 25, Gelonghui reported that China Resources Double-Crane Pharmaceutical (600062.SH) announced it has received the Pharmaceutical Registration Certificate for Gadobutrol Injection issued by the National Medical Products Administration. Gadobutrol Injection is suitable for MRI examinations of the following diseases: lesions of the brain and spinal cord, spinal lesions, and other systemic pathological examinations (including adult angiography), and its use is not recommended for children under 6 months old.
China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Missed Earnings: Here's What Analysts Think Will Happen Next
CR Double-Crane Pharmaceutical 2024 Profit Down 3%; Shares Decline 3%
China Resources Shuanghe: Summary of China Resources Shuanghe 2024 Annual Report
Earnings Update: Here's Why Analysts Just Lifted Their China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Price Target To CN¥24.91
